VALN:NASDAQ
Valneva SE
$6.57
arrow_downward
-0.15%(-0.0100) 1D
Sep 17, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VALN...
Open
$6.56
High
$6.78
Low
$6.56
Mkt. cap
626.49M
Avg. vol.
139.07K
Volume
0.00
52-wk high
$12.23
52-wk low
$4.75
EPS
-$1.80
Beta
1.67
Shares outstanding
94.89M
No. of employees
620
Open
$6.56
High
$6.78
Low
$6.56
Mkt. cap
626.49M
Avg. vol.
139.07K
Volume
0.00
52-wk high
$12.23
52-wk low
$4.75
EPS
-$1.80
Beta
1.67
Shares outstanding
94.89M
No. of employees
620
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
https://www.dars.gov.et/
·
2 months ago
Valneva Q1 2026 Earnings: EPS Misses Estimates Amid Rising R&D Costs - Operating Margin Analysis
Profile
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
About Valneva SE